BOSENTAN News
BOSENTAN currently has 0 news articles, with 14 predicted indications.
This page combines the AI-predicted indications for BOSENTAN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (14):
- systemic sclerosis (99.0%)
- pulmonary arterial hypertension (99.0%)
- scleroderma (disease) (99.0%)
- pulmonary hypertension (99.0%)
- localized scleroderma (99.0%)
- rheumatoid arthritis (99.8%)
- brachydactyly-syndactyly syndrome (99.7%)
- limited systemic sclerosis (99.7%)
- colobomatous microphthalmia-rhizomelic dysplasia syndrome (99.6%)
- pseudoxanthoma elasticum, forme fruste (99.5%)
- kyphoscoliotic heart disease (99.4%)
- elastoma (99.3%)
- gout (99.2%)
- hypertrichosis (disease) (99.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.